Acumen Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -45 | -44 | ||
EBITDA | -36,073 | -28,693 | -19,488 | -13,829 |
EBIT | -36,117 | -28,738 | -19,533 | -13,873 |
Net Income | -37,154 | -29,765 | -20,537 | -14,873 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -27,215 | -24,596 | -16,550 | -17,870 |
Cash | 35,627 | 33,184 | 67,955 | 46,930 |
Basic Shares | 60,046 | 60,079 | 60,079 | 59,812 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $1,436 |
Gross Profit | -42,318 | -169 | -4 | |
EBITDA | -98,083 | -51,606 | -42,687 | 61,577 |
EBIT | -98,261 | -51,790 | -42,856 | 61,573 |
Net Income | -102,329 | -52,371 | -40,475 | -181,679 |
Net Change In Cash | 0 | 0 | 0 | 1,436 |
Cost of Revenue | 7,939 | 78,385 | ||
Free Cash Flow | -86,231 | -43,085 | -35,314 | -18,001 |
Cash | 35,627 | 66,886 | 130,101 | 122,162 |
Basic Shares | 60,013 | 48,609 | 40,601 | 40,473 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.62 |
2024-09-30 | -$0.49 |
2024-06-30 | -$0.34 |
2024-03-31 | -$0.25 |
